Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. ALDURAZYME (laronidase)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

ALDURAZYME (laronidase)

Medicine - Posted on Feb 04 2022
Active substance (DCI)
  • laronidase
history (3)
  • 12/1/21

    ALDURAZYME 100 U/ml (laronidase)

    Réévaluation Avis favorable au maintien du remboursement dans le traitement enzymatique substitutif à long terme chez les pa...
    CAV :
    54321
    icône flèche
  • 3/8/17

    ALDURAZYME (laronidase), enzyme replacement

    Substantial clinical added value in mucopolysaccharidosis type I ALDURAZYME has marketing authorisation for long-term enzyme...
    CAV :
    54321
    icône flèche
  • 2/25/04

    ALDURAZYME (laronidase)

    ALDURAZYME (laronidase)
    icône flèche
Technical information
ATC code
  • A16AB05
Manufacturer
GENZYME S.A.S.
Presentation

ALDURAZYME 100 U/ml, solution à diluer pour perfusion (code CIS : 66328396)
1 flacon(s) en verre de 5 ml - (Code CIP : 34009 564 917 1 1)

All our publications
    Congenital, genetic and rare diseases Drug therapy Metabolic diseases Paediatrics

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
eNq1mF1v2jAUhu/5FVHuSaAFWqZAtbF2Q2o1Ros27aYyyaGYGTs9tvnor59DqJZOiToMvkxsn3Pi8/rxq0RXmyXzVoCSCt7zm0HD94DHIqH8qedPHm7ql/5VvxYtyIoUpl0EjaB55nsxI1L2/Gw0mALhMvh5d/sZzHpAv1/zIjFdQKzezNOKsuArkfM7kmZzvGglaOItQc1F0vNTrXZvvUgqNFX01wJ/y5TEEIX7N8XRxWOr+D4Ks2D/EVVLwFvCn0qDAreKGWtE4GpAFDwJ3FbUe24Vm8oxSKExhhFR8xGKFU0gKU0xI0yCVZLZOrkHXDFQWZLS4OEiXkqr4GRBNmN4HpYX/dGMDtRG1Rv15kWrc9Ftd5utbqNtlQoLW1XeBfMRYZpi8njWvTzvdLoh8JCwRCN52S6hzggKThNiuY9UjgQqwhy1icrBW6U5yoPw/K4cEipTRrbBQqa2W0WQmGFAwwN3H5J9wQMaQjGzZ//E55qx8MCqJ3t+OKo4w9NAaK4qMHIztt2IgeAKNtUdtSOf2uy1SEGeLuyL4OXUH+kpo7Et4wyFNEg1GQ+rEeeUDp/M0gm6w8MPyhOxlqfHTrHNjqpPd+QsDWo60sxa0mm229an6pfRVMUddK1RpBAaIFF5DGeGfCaOJYyRaXmoV5G60+fOGomYMKgwR3VL+hhhvno5Z9J3d6zygdKgX64fbPXyXQNu73ePpaFp0it22o7OLpBvBFpZ++Fyz0+9E+essZwmc6VS+SEM1+t1MCeyLonZpWCG7vFfuILdGXkn93zue3KEOip9mt+Nh7XM9vS95wSOdbf79XsXXZpDoYYjepGD2hlOh9enJ/Rfa+us7NEbnLhLs7OhRFHBXbkhPS23QsfeCaa1/MZwTH2bzWjFv5VKaUZh/l+nX4vC7J9Ov/YHbdsDkA==
Z6qtuSvkZKmR7Ech